
Sign up to save your podcasts
Or


Background
Our Guests
Dr. Stephen Lam: Professor of Medicine at the University of British Columbia and Medical Oncologist at BC Cancer. Dr. Lam is a Distinguished Scientist, and Leon Judah Blackmore Chair in Lung Cancer Research at the BC Cancer Research Center. He was the recipient of the Friesen-Rygiel Award for Outstanding Canadian Academic Discovery and the Gustav Killian Medal by the World Association of Bronchology for his pioneering contributions to the field of early lung cancer diagnosis, the Distinguished Achievement Award from the University of British Columbia and the Joseph Cullen Award for life-time scientific achievements in lung cancer prevention research by the International Association for the Study of Lung Cancer.
Dr. Rakesh Patel: General practitioner from Silverado Medical Clinic in Calgary, Alberta.
Resources
BC Press release http://www.bccancer.bc.ca/about/news-stories/news/2020/b-c-launches-lung-cancer-screening-program-%E2%80%93-the-first-in-canada
CPAC Report: https://s22457.pcdn.co/wp-content/uploads/2021/01/lung-cancer-screening-environmental-scan-2019-2020-Jan132021-EN.pdf
TO FIND A SCREENING PROGRAM NEAR YOU: https://right2survive.ca/resource-centre/screening/
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
Renseignements généraux
Invités
Dre Nicole Bouchard: Pneumologue au département de médecine de l’Université de Sherbrooke, Québec.
Dr Richard Dumouchel: Omnipraticien à la Clinique médicale du Coteau, à Saint-Jean-sur-Richelieu, Québec.
Résources
https://right2survive.ca/resource-centre/screening/
https://www.quebec.ca/en/health/advice-and-prevention/screening-and-carrier-testing-offer/lung-cancer-screening-demonstration-project
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
Background
Our Guests
Dr. Paul Wheatley-Price: Associate Professor in the Department of Medicine at the University of Ottawa and Medical Oncologist at The Ottawa Hospital Cancer Centre, specializing in the treatment of thoracic malignancies and carcinoma of unknown primary. Since 2016, Dr. Wheatley-Price has previously served as President of Lung Cancer Canada.
Dr. Jeffery Habert: General practitioner in Thornhill, ON and Assistant Professor in the Department of Family and Community Medicine at the University of Toronto.
Resources
ONTARIO
BRITISH COLUMBIA
CPAC Report: https://s22457.pcdn.co/wp-content/uploads/2021/01/lung-cancer-screening-environmental-scan-2019-2020-Jan132021-EN.pdf
TO FIND A SCREENING PROGRAM NEAR YOU: https://right2survive.ca/resource-centre/screening/
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
· The initiatives developed by Colorectal Cancer Canada to help progress access to genomic profiling and precision medicine for all cancer patients
· The patient’s perspective on education, access, and value of genomic profiling
· Access to genomic profiling in Quebec
· The value of IMPACT Medicom’s comprehensive genomic profiling prioritization report: https://www.impactmedicom.com/publications/reports
Our guest:
Barry D. Stein is the President and CEO of Colorectal Cancer Canada and is himself a survivor of metastatic colorectal cancer. He is an established lawyer in the fields of commercial and corporate law with GWBR, LLP in Montreal, where he dedicates a significant portion of his practice to labour law, as well as litigation in health and administrative law. Barry is the past president of the Coalition Priorité Cancer au Québec. He is also past chair of the IQVIA Advisory Council for the Advancement of Health in Quebec and a member of the Board of Directors of the Canadian Personalized Healthcare Innovation Network, EXACTIS Innovation, and the Quebec Clinical Research Organization in Cancer (Q-CROC).
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
In this episode of our podcast, we are joined by a very special guest, Dr. John Kuruvilla, who is an Associate Professor of Medicine at the University of Toronto and a Clinical Investigator in the Division of Medical Oncology and Hematology at Princess Margaret Hospital in Toronto.
We discuss:
This podcast episode is sponsored by Merck Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines.
In the third episode of the series, hosted by Anna Christofides (owner of IMPACT Medicom), we discuss with Dr. Raywat Deonandan:
Our guest
Dr. Ray Deonandan is an Epidemiologist and Associate Professor at the University of Ottawa, specializing in global health. Dr. Deonandan is a well-known science communicator, appearing on numerous news outlets throughout the COVID-19 pandemic in his effort to educate the public on the latest data.
This podcast episode is sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
Podcast details:
In this episode of IMPACT Medicom’s podcast series on Precision Medicine in Oncology we discuss:
· The evolving role of genomics in a pathologist’s tool kit for informing care in oncology
· The value of comprehensive genomic profiling (CGP) compared to single-gene tests
· The barriers to accessing CGP in Ontario
· What factors institutions should consider when deciding how to implement CGP
Our guest:
Dr. Brandon Sheffield is an anatomical pathologist at William Osler Health System in Brampton, Ontario, where he serves as Medical Director of Immunohistochemistry and Molecular Pathology, and Physician Lead of Research. He received his Doctor of Medicine at the University of Toronto and completed his anatomical pathology residency at the University of British Columbia. Given his interest in molecular genetic pathology, Dr. Sheffield played an integral role in acquiring William Osler’s new rapid comprehensive next generation sequencing technology, making Osler the first community hospital in the world to offer this type of genetic testing in-house for their cancer patients.
Brandon also served as a steering committee member on IMPACT Medicom’s CGP prioritization report. The full report can be downloaded at: https://www.impactmedicom.com/publications/reports
This podcast episode was sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines.
In the second episode of the series, hosted by Anna Christofides (owner of IMPACT Medicom), we discuss with Dr. Lynora Saxinger:
Our guest
Dr. Lynora Saxinger is a world-renowned infectious disease specialist, based at the University of Alberta. Dr. Saxinger has been at the forefront of the media, becoming a National public figure in the discussions around COVID-19.
This podcast episode is sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines.
In the second part of the first episode of the series, hosted by Anna Christofides (owner of IMPACT Medicom), we continue the discussion on:
Our guest
Dr. Kelly Grindrod is an associate professor at the University of Waterloo’s School of Pharmacy. She is the pharmacy lead for the Waterloo Region vaccine task force and helped set up a mass vaccine clinic at the University of Waterloo School of Pharmacy. Dr. Grindrod has also led the development of several online resources including the Pharmacy5in5.ca platform, which includes videos and infographics on COVID vaccines.
This podcast episode is sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
Episode is Live
Published: Apr. 14, 2021 @ 2PM Edit
Unpublish
Add a Transcript
Get episode better indexed by search engines.
Add Chapter Markers
Listeners can tap through & see what’s coming up.
Create a Visual Soundbite
Best way to share to social media for engagement.
Share Episode On
More Options
Email Link to Episode
Copy
Direct Link to MP3
Copy Download MP3
Embed this ONE Episode
Welcome to IMPACT Medicom’s MYTHBUSTER series, addressing COVID-19 vaccine hesitancy. This series is aimed at health care professionals who are on the front lines of vaccine delivery, to help address common sources of misinformation around COVID-19 vaccines.
In our first episode of the series, hosted by Anna Christofides (owner of IMPACT Medicom), we discuss with Dr. Kelly Grindrod:
Our guest
Dr. Kelly Grindrod is an associate professor at the University of Waterloo’s School of Pharmacy. She is the pharmacy lead for the Waterloo Region vaccine task force and helped set up a mass vaccine clinic at the University of Waterloo School of Pharmacy. Dr. Grindrod has also led the development of several online resources including the Pharmacy5in5.ca platform, which includes videos and infographics on COVID vaccines.
This podcast episode is sponsored by AstraZeneca Canada.
If you enjoy our podcast, please review and subscribe. For more podcasts, papers, and medical education programs, visit our website at: http://www.impactmedicom.com.
From the publisher's feed
We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic…

112,262 Listeners